ADPT Quote, Trading Chart, Adeptus Health

$39.82 Last:

4.9% Change Percent:

$37.5 Open:

$39.82 Previous Close:

$40.15 High:

$37.5 Low:

712,306 Volume:

06/17/2021 04:42:28 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2021-06-17	37.5	39.82	40.15	37.5	712,306
2021-06-16	37.62	37.96	38.695	37.14	459,694
2021-06-15	39.43	38.38	39.44	37.74	650,825
2021-06-14	38.56	39.14	39.48	38.31	573,702
2021-06-11	37.84	38.76	38.8	37.77	619,227
2021-06-10	35.86	37.92	38.27	35.41	620,426
2021-06-09	35.61	35.82	36.68	35.25	786,325
2021-06-08	38.03	35.32	38.34	35.17	1,499,113
2021-06-07	35.445	37.76	37.99	35.445	751,204
2021-06-04	35.73	35.93	36.81	35.615	233,771
2021-06-03	36.92	35.61	36.93	35.16	383,490
2021-06-02	36.92	37.14	37.5	36.5	408,815
2021-06-01	37.78	36.63	38.22	36.08	616,937
2021-05-31	38.04	37.81	39.229	37.76	676,529
2021-05-28	38.04	37.81	39.229	37.76	637,522
2021-05-27	37	37.82	37.93	35.67	710,451
2021-05-26	37.7	37.1	37.8	36.92	406,399
2021-05-25	36.89	37.42	37.67	36.58	498,299
2021-05-24	36.23	36.61	37	36.04	483,274
2021-05-21	36.49	36.12	37.56	35.99	1,110,640

Stock Information

Adeptus Health Company Name:

ADPT Stock Symbol:

NASDAQ Market:

Adeptus Health Website:

ADPT Quote, Trading Chart, Adeptus Health

Get ADPT Alerts

News, Short Squeeze, Breakout and More Instantly...

ADPT - New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern

SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that immunoSEQ &...
ADPT - Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

SEATTLE, June 03, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, will be included in more than 20 a...
ADPT - Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences

SEATTLE, May 20, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participa...